knowledge -WSS

knowledge

author：hotspot 2025-10-01 04:12:41 - browse：2452

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Teach medical students about patients with intellectual disabilities

knowledge

WSS

CRISPR base editing slashes cholesterol levels in monkeys

Americans' trust in science, scientist continues decline: Report

Congress extends some pandemic preparedness programs

The biotech scorecard for Q4: 16 stock

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

FDA needs staff influx to meet gene therapy needs, Marks says

leisure time

knowledge

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Chemotherapy shortages won’t get better under Biden’s latest plan

The cancer drug shortage isn’t new — and neither are the solutions

Chemotherapy shortages won’t get better under Biden’s latest plan

In Memoriam: Notable people who died in 2023

With Roe v Wade overturned, abortion providers work to adapt

Apple is now the first public company to be valued at $3 trillion

The woman behind the Dana Farber

United colonoscopy coverage change 'may cost lives,' doctors say

Health insurers' Q3 question: how much care are people getting?

Wikipedia

What PEPFAR has meant on the ground in Ukraine

European officials brace for rough respiratory virus season

Stop Congress from blocking public access to science

Will an HIV vaccine ever be a reality?

RSV injection headlines need to be accurate for good uptake

CMS should re

leisure time

entertainment

knowledge

knowledge